470 results
Page 18 of 24
8-K
EX-99
gs8 xe9ldeb321y
26 Jan 06
Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges
12:00am
8-K
EX-99
n7phq
20 Oct 05
Results of Operations and Financial Condition
12:00am
8-K
tnd7nvk45hvtoww8h
20 Sep 05
Entry into a Material Definitive Agreement
12:00am
8-K
763l8galir
8 Sep 05
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
EX-99
ih3yhk 1dlj
21 Jul 05
Lilly Reports Results for Second Quarter; Sales Increase 3 Percent Newer Products Contribute More Than $620 Million, or 17 Percent of Total Q2 Sales
12:00am
8-K
dxehqqds0j74wc
10 Jun 05
Lilly and Plaintiffs’ Attorneys Enter into an Agreement in Principle to Settle Majority of Zyprexa® Product Liability Litigation
12:00am
8-K
EX-99
6kplwd 2e
10 Jun 05
Lilly and Plaintiffs’ Attorneys Enter into an Agreement in Principle to Settle Majority of Zyprexa® Product Liability Litigation
12:00am
8-K
EX-99
90ki ecvtpkrkk0lew
18 Apr 05
Lilly Reports $.68 Earnings Per Share in the First Quarter Newer Products Contribute More Than $500 Million, or 14 Percent of Total Sales
12:00am